Inhibrx Biosciences Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$93.05

-1.15 (-1.22%)

As of Jun 21, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 78%

Hold 2 22%

Sell 0 0%

Price Target

Analyst Price Target -80.5% upside

Low Target $12.39

Average Target $18.13

High Target $27.56

Current Price $93.05

Current
$93.05

Target
$18.13

$12.39 $18.13 avg $27.56

Scenario Analysis

Bear Case

$12.39

-86.7%

Low target

Base Case

$18.13

-80.5%

Avg target

Bull Case

$27.56

+-70.4%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$155.29

-40.1% from high

52-Week Low

$13.97

+566.1% from low

Target vs 52W High

$18.13

-88.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+5.7%
AMGN Amgen Inc	Hold	44	50%	$190.87	-46.4%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+191.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-9.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-36.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.5%